ArticleACS nano2022

Systemically Administered TLR7/8 Agonist and Antigen-Conjugated Nanogels Govern Immune Responses against Tumors.

Judith Stickdorn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.